{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:23:56Z","timestamp":1786119836813,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1097\/rlu.0b013e318219b49d","type":"journal-article","created":{"date-parts":[[2011,6,29]],"date-time":"2011-06-29T07:37:08Z","timestamp":1309333028000},"page":"656-660","source":"Crossref","is-referenced-by-count":20,"title":["Attention Deficit\/Hyperactivity Disorder"],"prefix":"10.1097","volume":"36","author":[{"given":"Neivo","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia M.","family":"Szobot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E.","family":"Anselmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea P.","family":"Jackowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih M.","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Q.","family":"Hoexter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osvaldo E.","family":"Anselmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Pechansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo A.","family":"Bressan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210204","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1176\/ajp.2007.164.6.942","article-title":"The worldwide prevalence of ADHD: a systematic review and metaregression analysis.","volume":"164","author":"Polanczyk","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R2-4-20210204","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.biopsych.2004.11.024","article-title":"Molecular genetics of attention-deficit\/hyperactivity disorder.","volume":"57","author":"Faraone","year":"2005","journal-title":"Biol Psychiatry"},{"key":"R3-4-20210204","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pediatrneurol.2005.04.008","article-title":"Dopamine transporter in attention-deficit hyperactivity disorder normalizes after cessation of methylphenidate.","volume":"33","author":"Feron","year":"2005","journal-title":"Pediatr Neurol"},{"key":"R4-4-20210204","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.mnm.0000230077.48480.68","article-title":"Value of 99mTc-TRODAT-1 SPECT to predict clinical response to methylphenidate treatment in adults with attention deficit hyperactivity disorder.","volume":"27","author":"la Fougere","year":"2006","journal-title":"Nucl Med Commun"},{"key":"R5-4-20210204","first-page":"993","article-title":"Association of attention-deficit disorder and the dopamine transporter gene.","volume":"56","author":"Cook","year":"1995","journal-title":"Am J Hum Genet"},{"key":"R6-4-20210204","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1586\/14737175.8.4.611","article-title":"SPECT and PET of the dopamine transporter in attention-deficit\/hyperactivity disorder.","volume":"8","author":"Krause","year":"2008","journal-title":"Expert Rev Neurother"},{"key":"R7-4-20210204","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00259-002-1047-3","article-title":"Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder.","volume":"30","author":"Cheon","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R8-4-20210204","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.neuroimage.2005.10.029","article-title":"Brain hemodynamic changes mediated by dopamine receptors: role of the cerebral microvasculature in dopamine-mediated neurovascular coupling.","volume":"30","author":"Choi","year":"2006","journal-title":"Neuroimage"},{"key":"R9-4-20210204","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/00004647-200112000-00001","article-title":"Relationship of spikes, synaptic activity, and local changes of cerebral blood flow.","volume":"21","author":"Lauritzen","year":"2001","journal-title":"J Cereb Blood Flow Metab"},{"key":"R10-4-20210204","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1523\/JNEUROSCI.23-10-03963.2003","article-title":"The underpinnings of the BOLD functional magnetic resonance imaging signal.","volume":"23","author":"Logothetis","year":"2003","journal-title":"J Neurosci"},{"key":"R11-4-20210204","doi-asserted-by":"crossref","first-page":"9553","DOI":"10.1523\/JNEUROSCI.1558-04.2004","article-title":"Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.","volume":"24","author":"Jenkins","year":"2004","journal-title":"J Neurosci"},{"key":"R12-4-20210204","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1360-0443.2007.01850.x","article-title":"Is attention-deficit\/hyperactivity disorder associated with illicit substance use disorders in male adolescents? A community-based case\u2013control study?","volume":"102","author":"Szobot","year":"2007","journal-title":"Addiction"},{"key":"R13-4-20210204","article-title":"K-SADS. 1ed.","author":"Mercadante","year":"1995"},{"key":"R14-4-20210204","article-title":"Schedule for Affective Disorders and Schizophrenia for School-Age Children: Epidemiologic. 4th version.","author":"Orvaschel","year":"1987"},{"key":"R15-4-20210204","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00004583-200102000-00011","article-title":"Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.","volume":"40","author":"Swanson","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R16-4-20210204","article-title":"Examiner's Manual: Wechsler Intelligence Scale for Children. 3rd ed.","author":"Wechsler","year":"1991"},{"key":"R17-4-20210204","article-title":"Co-planar Stereotaxic Atlas of Human Brain.","author":"Talairach","year":"1988"},{"key":"R18-4-20210204","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0925-4927(00)00050-0","article-title":"A voxel-based investigation of regional cerebral blood flow abnormalities in obsessive-compulsive disorder using single photon emission computed tomography (SPECT).","volume":"99","author":"Busatto","year":"2000","journal-title":"Psychiatry Res"},{"key":"R19-4-20210204","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00406-005-0602-x","article-title":"Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD.","volume":"255","author":"Krause","year":"2005","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R20-4-20210204","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3940(00)01040-5","article-title":"Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography.","volume":"285","author":"Krause","year":"2000","journal-title":"Neurosci Lett"},{"key":"R21-4-20210204","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1007\/s002590000330","article-title":"Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment.","volume":"27","author":"Dresel","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"R22-4-20210204","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0006-8993(83)91016-8","article-title":"Apomorphine-induced changes in local cerebral blood flow in normal rats and after lesions of the dopaminergic nigrostriatal bundle.","volume":"262","author":"Ingvar","year":"1983","journal-title":"Brain Res"},{"key":"R23-4-20210204","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/jcbfm.1994.132","article-title":"Effects of blood flow on [11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data.","volume":"14","author":"Logan","year":"1994","journal-title":"J Cereb Blood Flow Metab"},{"key":"R24-4-20210204","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0969-8051(02)00450-X","article-title":"Kinetic modelling of [123I]CNS 1261\u2014a potential SPET tracer for the NMDA receptor.","volume":"30","author":"Erlandsson","year":"2003","journal-title":"Nucl Med Biol"},{"key":"R25-4-20210204","first-page":"830","article-title":"Associations between cerebral blood-flow measured by single photon emission computed tomography (SPECT), electro-encephalogram (EEG), behaviour symptoms, cognition and neurological soft signs in children with attention-deficit hyperactivity disorder (ADHD).","volume":"89","author":"Gustafsson","year":"2000","journal-title":"Acta Paediatr"},{"key":"R26-4-20210204","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/BF02988629","article-title":"Technetium-99m HMPAO brain SPECT in children with attention deficit hyperactivity disorder.","volume":"16","author":"Kaya","year":"2002","journal-title":"Ann Nucl Med"},{"key":"R27-4-20210204","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00406-002-0384-3","article-title":"Regional cerebral perfusion abnormalities in attention deficit\/hyperactivity disorder. Statistical parametric mapping analysis.","volume":"252","author":"Kim","year":"2002","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R28-4-20210204","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.neuroimage.2007.12.050","article-title":"Methylphenidate DAT binding in adolescents with Attention-Deficit\/Hyperactivity Disorder comorbid with Substance Use Disorder\u2014a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study.","volume":"40","author":"Szobot","year":"2008","journal-title":"Neuroimage"},{"key":"R29-4-20210204","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00259-002-1082-0","article-title":"The acute effect of methylphenidate on cerebral blood flow in boys with attention-deficit\/hyperactivity disorder.","volume":"30","author":"Szobot","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R30-4-20210204","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3349\/ymj.2001.42.1.19","article-title":"Methylphenidate increased regional cerebral blood flow in subjects with attention deficit\/hyperactivity disorder.","volume":"42","author":"Kim","year":"2001","journal-title":"Yonsei Med J"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003072-201108000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:31:19Z","timestamp":1786044679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003072-201108000-00004"}},"subtitle":["Is There a Correlation Between Dopamine Transporter Density and Cerebral Blood Flow?"],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0b013e318219b49d","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}